Patents by Inventor Meehyung Cho

Meehyung Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic tyrosine kinase inhibitors for relapsing multiple sclerosis (RMS)
    Patent number: 11969418
    Abstract: This disclosure relates to the field of therapeutic tyrosine kinase inhibitors, in particular Bruton tyrosine kinase (“BTK”) inhibitors for treatment of subjects with relapsing multiple sclerosis.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: April 30, 2024
    Assignee: GENZYME CORPORATION
    Inventors: Meehyung Cho, Timothy J. Turner, Erik Wallstroem
  • Therapeutic Tyrosine Kinase Inhibitors for Relapsing Multiple Sclerosis (RMS)
    Publication number: 20210244720
    Abstract: This disclosure relates to the field of therapeutic tyrosine kinase inhibitors, in particular Bruton tyrosine kinase (“BTK”) inhibitors for treatment of subjects with relapsing multiple sclerosis.
    Type: Application
    Filed: January 19, 2021
    Publication date: August 12, 2021
    Applicant: Genzyme Corporation
    Inventors: Meehyung Cho, Timothy J. Turner, Erik Wallstroem